NCT03949543

Brief Summary

The interplay between diet and the gut microbiota has been implicated in the onset of cardiovascular disease. The gut microbiota displays diurnal rhythms, which may be influenced by meal timing. This study aimed to investigate the effect of main meal consumption timing on the microbiota and the cardiometabolic factors of the host using a cross-over RCT in healthy adults The main outcome measurements will be: a) changes in gut microbiota composition based on 16S rRNA gene amplicon sequencing and shotgun metagenomics, b) changes in bacterial functional capacity) and urinary/faecal metabolomics, c) changes in targeted bacterial metabolites, d)Inflammatory markers The aim of this study is to explore the effect of the timing of main meal consumption on gut microbiota and immune response in healthy adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 10, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 28, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 28, 2018

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

May 9, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 14, 2019

Completed
Last Updated

May 15, 2019

Status Verified

May 1, 2019

Enrollment Period

8 months

First QC Date

May 9, 2019

Last Update Submit

May 13, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Gut microbiome alpha diversity

    Shannon diversity index

    7 days post-intervention

  • Faecal short chain fatty acids

    Short chain fatty acids (umol/g)

    7 days post-intervention

Secondary Outcomes (7)

  • HDL

    7 days post-intervention

  • LDL

    7 days post-intervention

  • Triglycerides

    7 days post-intervention

  • Glucose

    7 days post-intervention

  • Insulin

    7 days post-intervention

  • +2 more secondary outcomes

Study Arms (2)

Healthy Adult Participants A

EXPERIMENTAL

Participants who will get two interventional diets, for 7 days each, but allocated to start with large lunch intervention

Other: Large Lunch InterventionOther: Large Dinner Intervention

Healthy Adult Participants B

EXPERIMENTAL

Participants who will get two interventional diets, for 7 days each, but allocated to start with large dinner intervention

Other: Large Lunch InterventionOther: Large Dinner Intervention

Interventions

Participants were asked to consume 60% of their daily energy requirements as lunch, between 12:30 and 13:30. Breakfast accounted for 15% of their total daily energy, a morning and evening snack for 5%. 15% was given for light meal either as dinner.

Healthy Adult Participants AHealthy Adult Participants B

Participants were asked to consume 60% of their daily energy requirements as dinner, between 19:30 and 20:30, each day during their two dietary interventions. Breakfast accounted for 15% of their total daily energy, a morning and evening snack for 5%. 15% was given for light meal either as lunch.

Healthy Adult Participants AHealthy Adult Participants B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \) Healthy adult people

You may not qualify if:

  • History of gut surgery
  • Use of antibiotics or steroids the last 3 months
  • Positive or negative energy balance (recent weight gain or loss, ±2 Kg the past month)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Medicine, University of Glasgow / New Lister Building, Glasgow Royal Infirmary

Glasgow, G312ER, United Kingdom

Location

MeSH Terms

Conditions

Feeding Behavior

Condition Hierarchy (Ancestors)

Behavior, AnimalBehavior

Study Officials

  • Konstantinos Gerasimidis, BSc MSc PhD

    University of Glasgow

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Lecturer in Clinical Nutrition

Study Record Dates

First Submitted

May 9, 2019

First Posted

May 14, 2019

Study Start

October 10, 2017

Primary Completion

May 28, 2018

Study Completion

May 28, 2018

Last Updated

May 15, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations